Verition Fund Management
RDY icon

Verition Fund Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Verition Fund Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-36,235
Closed -$509K – 3312
2025
Q4 		$509K Buy
36,235
+18,011
+99% +$253K ﹤0.01% 2646
2025
Q3 		$255K Sell
18,224
-241,279
-93% -$3.47M ﹤0.01% 3375
2025
Q2 		$3.9M Buy
259,503
+156,515
+152% +$2.24M 0.02% 1368
2025
Q1 		$1.36M Buy
+102,988
New +$1.42M 0.01% 1874
2018
Q3 		– Sell
-47,970
Closed -$309K – 1414
2018
Q2 		$309K Buy
+47,970
New +$303K 0.02% 843

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Verition Fund Management's RDY Position: Q1 2026 in Review

Verition Fund Management sold out of Dr. Reddy's Laboratories (RDY) in Q1 2026, closing a stake of 36,235 shares — an estimated $509K sold.

Verition Fund Management first reported a position in RDY in Q2 2018 and held it in 5 quarters. The position peaked at $3.9M in Q2 2025. 247 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

  • Verition Fund Management reported no remaining Dr. Reddy's Laboratories position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 36,235 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $509K.
  • Verition Fund Management first reported a position in Dr. Reddy's Laboratories in Q2 2018 and held it in 5 quarters.
  • Verition Fund Management's Dr. Reddy's Laboratories position peaked at $3.9M in Q2 2025.
  • 247 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.